Clinical Trial Update: Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS [NA]

View source ↗

Summary

A completed clinical trial evaluating immunoadsorption in myalgic encephalomyelitis/chronic fatigue syndrome, including patients with Post-COVID ME/CFS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: ME/CFS, Post-COVID ME/CFS | NA | Status: COMPLETED